Alexander Gelbard
Last active: 7/30/2020

  1. Cell-intrinsic role for IFN-α-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Li HS, Gelbard A, Martinez GJ, Esashi E, Zhang H, Nguyen-Jackson H, Liu YJ, Overwijk WW, Watowich SS (2011) Blood 118(14): 3879-89
    › Primary publication · 21828128 (PubMed) · PMC3193265 (PubMed Central)
  2. Antitumor activity mediated by CpG: the route of administration is critical. Lou Y, Liu C, Lizée G, Peng W, Xu C, Ye Y, Rabinovich BA, Hailemichael Y, Gelbard A, Zhou D, Overwijk WW, Hwu P (2011) J Immunother 34(3): 279-88
    › Primary publication · 21389870 (PubMed) · PMC6119202 (PubMed Central)
  3. An information theoretic, microfluidic-based single cell analysis permits identification of subpopulations among putatively homogeneous stem cells. Glotzbach JP, Januszyk M, Vial IN, Wong VW, Gelbard A, Kalisky T, Thangarajah H, Longaker MT, Quake SR, Chu G, Gurtner GC (2011) PLoS One 6(6): e21211
    › Primary publication · 21731674 (PubMed) · PMC3120839 (PubMed Central)
  4. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Sikora AG, Gelbard A, Davies MA, Sano D, Ekmekcioglu S, Kwon J, Hailemichael Y, Jayaraman P, Myers JN, Grimm EA, Overwijk WW (2010) Clin Cancer Res 16(6): 1834-44
    › Primary publication · 20215556 (PubMed) · PMC2858983 (PubMed Central)
  5. Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model. Kong LY, Gelbard A, Wei J, Reina-Ortiz C, Wang Y, Yang EC, Hailemichael Y, Fokt I, Jayakumar A, Qiao W, Fuller GN, Overwijk WW, Priebe W, Heimberger AB (2010) Clin Cancer Res 16(9): 2550-61
    › Primary publication · 20388845 (PubMed) · PMC2936966 (PubMed Central)
  6. Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy. Thapa P, Zhang G, Xia C, Gelbard A, Overwijk WW, Liu C, Hwu P, Chang DZ, Courtney A, Sastry JK, Wang PG, Li C, Zhou D (2009) Vaccine 27(25-26): 3484-8
    › Primary publication · 19200815 (PubMed) · PMC5772602 (PubMed Central)
  7. IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity. Sikora AG, Jaffarzad N, Hailemichael Y, Gelbard A, Stonier SW, Schluns KS, Frasca L, Lou Y, Liu C, Andersson HA, Hwu P, Overwijk WW (2009) J Immunol 182(12): 7398-407
    › Primary publication · 19494262 (PubMed) · PMC2774140 (PubMed Central)
  8. Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects. Chakraborty M, Gelbard A, Carrasquillo JA, Yu S, Mamede M, Paik CH, Camphausen K, Schlom J, Hodge JW (2008) Cancer Immunol Immunother 57(8): 1173-83
    › Primary publication · 18256832 (PubMed)
  9. An orthotopic murine model of sinonasal malignancy. Gelbard A, Kupferman ME, Jasser SA, Chen W, El-Naggar AK, Myers JN, Hanna EY (2008) Clin Cancer Res 14(22): 7348-57
    › Primary publication · 19010850 (PubMed) · PMC5428892 (PubMed Central)
  10. Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis. Gelbard A, Garnett CT, Abrams SI, Patel V, Gutkind JS, Palena C, Tsang KY, Schlom J, Hodge JW (2006) Clin Cancer Res 12(6): 1897-905
    › Primary publication · 16551875 (PubMed) · PMC1865094 (PubMed Central)